Journal of Archives in Military Medicine

Published by: Kowsar

Calcitonin Injection and Functional Status of Females With Knee Osteoarthritis

Attiyeh Vasaghi 1 , 2 , Mahdieh Karimizadeh 3 and Alireza Ashraf 1 , 4 , *
Authors Information
1 Department of Physical Medicine and Rehabilitation, Shahid Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Pediatrics, Shahid Beheshti Universuty of Medical Sciences, Tehran, IR Iran
4 Shiraz Geriatric Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Journal of Archives in Military Medicine: August 01, 2016, 4 (3); e38493
  • Published Online: August 6, 2016
  • Article Type: Research Article
  • Received: April 15, 2016
  • Revised: July 30, 2016
  • Accepted: July 30, 2016
  • DOI: 10.5812/jamm.38493

To Cite: Vasaghi A, Karimizadeh M, Ashraf A. Calcitonin Injection and Functional Status of Females With Knee Osteoarthritis, J Arch Mil Med. 2016 ; 4(3):e38493. doi: 10.5812/jamm.38493.

Abstract
Copyright © 2016, AJA University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Esenyel M, Icagasioglu A, Esenyel CZ. Effects of calcitonin on knee osteoarthritis and quality of life. Rheumatol Int. 2013; 33(2): 423-7[DOI][PubMed]
  • 2. Walker-Bone K, Javaid K, Arden N, Cooper C. Regular review: medical management of osteoarthritis. BMJ. 2000; 321(7266): 936-40[PubMed]
  • 3. Papaioannou NA, Triantafillopoulos IK, Khaldi L, Krallis N, Galanos A, Lyritis GP. Effect of calcitonin in early and late stages of experimentally induced osteoarthritis. A histomorphometric study. Osteoarthritis Cartilage. 2007; 15(4): 386-95[DOI][PubMed]
  • 4. Felson DT, Neogi T. Osteoarthritis: is it a disease of cartilage or of bone? Arthritis Rheum. 2004; 50(2): 341-4[DOI][PubMed]
  • 5. Karsdal MA, Leeming DJ, Dam EB, Henriksen K, Alexandersen P, Pastoureau P, et al. Should subchondral bone turnover be targeted when treating osteoarthritis? Osteoarthritis Cartilage. 2008; 16(6): 638-46[DOI][PubMed]
  • 6. Abramson SB, Attur M, Yazici Y. Prospects for disease modification in osteoarthritis. Nat Clin Pract Rheumatol. 2006; 2(6): 304-12[DOI][PubMed]
  • 7. Karsdal MA, Tanko LB, Riis BJ, Sondergard BC, Henriksen K, Altman RD, et al. Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA? Osteoarthritis Cartilage. 2006; 14(7): 617-24[DOI][PubMed]
  • 8. Karsdal MA, Henriksen K, Arnold M, Christiansen C. Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality. BioDrugs. 2008; 22(3): 137-44[PubMed]
  • 9. Tanko LB, Bagger YZ, Alexandersen P, Devogelaer JP, Reginster JY, Chick R, et al. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover. J Bone Miner Res. 2004; 19(9): 1531-8[DOI][PubMed]
  • 10. Badurski J, Jeziernicka E, Naruszewicz K, Racewicz A. [Comparative analysis of three treatment regimens for treating gonarthritis with calcitonin, naproxen and flavonoids based on EULAR criteria and visual analogue scale (VAS)]. Pol Tyg Lek. 1995; 50(44-47): 37-40[PubMed]
  • 11. Hellio MP, Peschard MJ, Cohen C, Richard M, Vignon E. Calcitonin inhibits phospholipase A2 and collagenase activity of human osteoarthritic chondrocytes. Osteoarthritis Cartilage. 1997; 5(2): 121-8[PubMed]
  • 12. Siamopoulou A, Challa A, Kapoglou P, Cholevas V, Mavridis AK, Lapatsanis PD. Effects of intranasal salmon calcitonin in juvenile idiopathic arthritis: an observational study. Calcif Tissue Int. 2001; 69(1): 25-30[PubMed]
  • 13. Karsdal MA, Sondergaard BC, Arnold M, Christiansen C. Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis? Ann N Y Acad Sci. 2007; 1117: 181-95[DOI][PubMed]
  • 14. Behets C, Williams JM, Chappard D, Devogelaer JP, Manicourt DH. Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency. J Bone Miner Res. 2004; 19(11): 1821-6[DOI][PubMed]
  • 15. Karsdal MA, Byrjalsen I, Bay-Jensen AC, Henriksen K, Riis BJ, Christiansen C. Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation. BMC Musculoskelet Disord. 2010; 11: 125[DOI][PubMed]
  • 16. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957; 16(4): 494-502[PubMed]
  • 17. Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum. 2001; 45(4): 384-91[DOI][PubMed]
  • 18. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988; 15(12): 1833-40[PubMed]
  • 19. Bagger YZ, Tanko LB, Alexandersen P, Karsdal MA, Olson M, Mindeholm L, et al. Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. Bone. 2005; 37(3): 425-30[DOI][PubMed]
  • 20. Manicourt DH, Azria M, Mindeholm L, Thonar EJ, Devogelaer JP. Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum. 2006; 54(10): 3205-11[DOI][PubMed]
  • 21. Armagan O, Serin DK, Calisir C, Dokumacioglu A, Ozgen M, Oner S, et al. Inhalation therapy of calcitonin relieves osteoarthritis of the knee. J Korean Med Sci. 2012; 27(11): 1405-10[DOI][PubMed]
  • 22. Ashraf A, Khodadadi M, Sadraei A, Naseri M, Nasseri A. The efficacy of intramuscular calcitonin injection in the management of lumbar spinal stenosis. Asian Spine J. 2015; 9(1): 75-82[DOI][PubMed]
  • 23. Raheb G, Khani A, Jandaghi J, Khoshnami MS. Evaluating the Level of Learning Motivation Among the Rehabilitation Students at the University of Social Welfare and Rehabilitation Sciences of Tehran, Iran; During 2011-2012. Middle East J Rehabil Health. 2014; 1(2)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments